Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125405743 | 12540574 | 3 | F | 20160526 | 20160714 | 20160708 | 20160729 | EXP | IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119930 | RANBAXY | 86.54 | YR | F | Y | 57.00000 | KG | 20160729 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125405743 | 12540574 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 25 MG DAILY | U | U | 91258 | 25 | MG | ||||||
| 125405743 | 12540574 | 2 | I | OLANZAPINE. | OLANZAPINE | 1 | Oral | 5 MG DAILY | U | U | 0 | 5 | MG | ||||||
| 125405743 | 12540574 | 3 | I | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 1 DF DAILY | U | U | 0 | 1 | DF | ||||||
| 125405743 | 12540574 | 4 | I | Amiodarone | AMIODARONE | 1 | Intravenous (not otherwise specified) | Y | U | 0 | |||||||||
| 125405743 | 12540574 | 5 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | U | U | 0 | |||||||||
| 125405743 | 12540574 | 6 | C | HALCION 125 MCG | 2 | Oral | 1 DF | U | U | 0 | 1 | DF | |||||||
| 125405743 | 12540574 | 7 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 0.5 DF | U | U | 0 | .5 | DF | ||||||
| 125405743 | 12540574 | 8 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 1.25 MG | U | U | 0 | 1.25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125405743 | 12540574 | 1 | Product used for unknown indication |
| 125405743 | 12540574 | 2 | Product used for unknown indication |
| 125405743 | 12540574 | 3 | Product used for unknown indication |
| 125405743 | 12540574 | 4 | Atrial fibrillation |
| 125405743 | 12540574 | 5 | Product used for unknown indication |
| 125405743 | 12540574 | 6 | Product used for unknown indication |
| 125405743 | 12540574 | 7 | Product used for unknown indication |
| 125405743 | 12540574 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125405743 | 12540574 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125405743 | 12540574 | Drug interaction | |
| 125405743 | 12540574 | Electrocardiogram QT prolonged | |
| 125405743 | 12540574 | Extrasystoles | |
| 125405743 | 12540574 | Torsade de pointes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125405743 | 12540574 | 4 | 20160526 | 20160526 | 0 |